Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04024631

Phenotyping Genetic Risk for Type 2 Diabetes

Phenotyping Children and Adults With Possible High or Low Genetic Risk for Type 2 Diabetes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
10 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.

Detailed description

The study team will recruit individuals based on genetic risk score for type 2 diabetes from the biobank populations who have agreed to be recontacted for future research. Each participant will undergo a frequently sampled four-hour oral glucose tolerance test and whole body DXA scan (dual-energy X-ray absorptiometry) in addition to baseline laboratory and history assessment.

Conditions

Interventions

TypeNameDescription
OTHER75g glucose beverage (Glucola, Trutol, or similar brand)Subjects will present fasting to the study day and ingest the glucose beverage during the oral glucose tolerance test.
OTHERDXA, whole bodySubjects will undergo a whole body DXA scan for assessment of adiposity index and body fat distribution.

Timeline

Start date
2019-06-17
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2019-07-18
Last updated
2025-09-10

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04024631. Inclusion in this directory is not an endorsement.

Phenotyping Genetic Risk for Type 2 Diabetes (NCT04024631) · Clinical Trials Directory